Blog

Careers

Advertise

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News

HSCA Submits Comments to ANSI on Healthcare Supply Chain Data Standards to Help Improve Accuracy, Efficiency, and Patient Safety

November 26, 2019 by Brigid Hasson 2019 Press Releases 0 comments

Washington, DC (November 26, 2019) – The Healthcare Supply Chain Association (HSCA) Committee for Healthcare eStandards (CHeS) today submitted comments to the American National Standards Institute’s (ANSI) Accredited Standards Committee (ASC) X12 supporting the Committee’s recommendation to include medical device identifiers in the healthcare electronic claim form.

The vast majority of healthcare insurance claims are communicated electronically, using electronic data interchange (EDI) standards that are promulgated and maintained by the ASC X12 Committee. The ANSI ASC X12 Committee is currently proposing a number of changes to the electronic healthcare claim form, including adding medical device identifiers to the form to enable providers and payers to exchange product information.

Click here to read the full release.

Prev
Next

Related Posts

HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
October 5, 2020

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
HSCA Statement on FDA Drug Shortages Task Force Report
October 29, 2019

Washington, DC (October 29, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more
Comments of the Healthcare Supply Chain Association on USTR Request for Comments on Additional Tariff Exclusions for COVID-19 Response
May 14, 2020

Dear Ambassador Lighthizer: On behalf of the Healthcare Supply Chain...

Learn more
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 11, 2019

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Statement on President Biden’s Executive Order on America’s Supply Chains
    February 25, 2021
  • HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
    February 5, 2021